hrcak mascot   Srce   HID

Ostalo

TREATMENT OF ANEMIA IN CHRONIC KIDNEY DISEASE – POSITION STATEMENT OF THE CROATIAN SOCIETY FOR NEPHROLOGY, DIALYSIS AND TRANSPLANTATION AND REVIEW OF THE KDIGO AND ERPB GUIDELINES

SANJIN RAČKI   ORCID icon orcid.org/0000-0002-3736-0929 ; Rijeka University Hospital Center, Department of Nephrology and Dialysis, Rijeka, Croatia
NIKOLINA BAŠIĆ-JUKIĆ ; Clinical Department of Pediatrics, Department of Children Nephrology, Dialysis and Transplantation, Zagreb, Croatia
PETAR KES ; Clinical Department of Pediatrics, Department of Children Nephrology, Dialysis and Transplantation, Zagreb, Croatia
DRAGAN LJUTIĆ ; Split University Hospital Center, Split, Croatia
VESNA LOVČIĆ ; Bjelovar General Hospital, Bjelovar, Croatia
INGRID PRKAČIN ; Merkur University Hospital, Department of Nephrology and Dialysis, Zagreb, Croatia
JOSIPA RADIĆ ; Split University Hospital Center, Split, Croatia
BOŽIDAR VUJIČIĆ ; Rijeka University Hospital Center, Department of Nephrology and Dialysis, Rijeka, Croatia
IVAN BUBIĆ ; Rijeka University Hospital Center, Department of Nephrology and Dialysis, Rijeka, Croatia
MARKO JAKIĆ ; Osijek University Hospital Center, Department of Nephrology and Dialysis, Osijek, Croatia
ŽARKO BELAVIĆ ; Fresenius Medical Care
SINIŠA ŠEFER ; Sestre milosrdnice Zagreb University Hospital Center, Department of Nephrology and Dialysis, Zagreb, Croatia
MARIO PEHAR ; Dubrava University Hospital, Department of Nephrology and Dialysis, Zagreb, Croatia
DRAGAN KLARIĆ ; Zadar General Hospital, Zadar, Croatia
MARIJANA GULIN ; Šibenik General Hospital, Šibenik, Croatia

Puni tekst: hrvatski, pdf (139 KB) str. 215-220 preuzimanja: 836* citiraj
APA 6th Edition
RAČKI, S., BAŠIĆ-JUKIĆ, N., KES, P., LJUTIĆ, D., LOVČIĆ, V., PRKAČIN, I., ... GULIN, M. (2014). LIJEČENJE ANEMIJE U KRONIČNOJ BUBREŽNOJ BOLESTI – STAV HRVATSKOG DRUŠTVA ZA NEFROLOGIJU, DIJALIZU I TRANSPLANTACIJU I OSVRT NA PREPORUKE KDIGO I ERBP. Acta medica Croatica, 68 (2), 215-220. Preuzeto s https://hrcak.srce.hr/126932
MLA 8th Edition
RAČKI, SANJIN, et al. "LIJEČENJE ANEMIJE U KRONIČNOJ BUBREŽNOJ BOLESTI – STAV HRVATSKOG DRUŠTVA ZA NEFROLOGIJU, DIJALIZU I TRANSPLANTACIJU I OSVRT NA PREPORUKE KDIGO I ERBP." Acta medica Croatica, vol. 68, br. 2, 2014, str. 215-220. https://hrcak.srce.hr/126932. Citirano 13.12.2019.
Chicago 17th Edition
RAČKI, SANJIN, NIKOLINA BAŠIĆ-JUKIĆ, PETAR KES, DRAGAN LJUTIĆ, VESNA LOVČIĆ, INGRID PRKAČIN, JOSIPA RADIĆ, et al. "LIJEČENJE ANEMIJE U KRONIČNOJ BUBREŽNOJ BOLESTI – STAV HRVATSKOG DRUŠTVA ZA NEFROLOGIJU, DIJALIZU I TRANSPLANTACIJU I OSVRT NA PREPORUKE KDIGO I ERBP." Acta medica Croatica 68, br. 2 (2014): 215-220. https://hrcak.srce.hr/126932
Harvard
RAČKI, S., et al. (2014). 'LIJEČENJE ANEMIJE U KRONIČNOJ BUBREŽNOJ BOLESTI – STAV HRVATSKOG DRUŠTVA ZA NEFROLOGIJU, DIJALIZU I TRANSPLANTACIJU I OSVRT NA PREPORUKE KDIGO I ERBP', Acta medica Croatica, 68(2), str. 215-220. Preuzeto s: https://hrcak.srce.hr/126932 (Datum pristupa: 13.12.2019.)
Vancouver
RAČKI S, BAŠIĆ-JUKIĆ N, KES P, LJUTIĆ D, LOVČIĆ V, PRKAČIN I i sur. LIJEČENJE ANEMIJE U KRONIČNOJ BUBREŽNOJ BOLESTI – STAV HRVATSKOG DRUŠTVA ZA NEFROLOGIJU, DIJALIZU I TRANSPLANTACIJU I OSVRT NA PREPORUKE KDIGO I ERBP. Acta medica Croatica [Internet]. 2014 [pristupljeno 13.12.2019.];68(2):215-220. Dostupno na: https://hrcak.srce.hr/126932
IEEE
S. RAČKI, et al., "LIJEČENJE ANEMIJE U KRONIČNOJ BUBREŽNOJ BOLESTI – STAV HRVATSKOG DRUŠTVA ZA NEFROLOGIJU, DIJALIZU I TRANSPLANTACIJU I OSVRT NA PREPORUKE KDIGO I ERBP", Acta medica Croatica, vol.68, br. 2, str. 215-220, 2014. [Online]. Dostupno na: https://hrcak.srce.hr/126932. [Citirano: 13.12.2019.]

Sažetak
Renal anemia is the result of chronic kidney disease (CKD) and deteriorates with disease progression. Anemia may be the first sign of kidney disease. In all patients with anemia and CKD, diagnostic evaluation is required. Prior to diagnosing renal anemia, it is necessary to eliminate the other possible causes. Direct correlation between the concentration of hemoglobin and the stage of renal failure is well known. Early development of anemia is common in diabetic patients. Correction of anemia may slow the progression of CKD. Anemia is an independent risk factor for developing cardiovascular disease in patients with CKD. Treatment of anemia in patients with CKD is based on current guidelines. Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group has produced comprehensive clinical practice guidelines for the management of anemia in CKD patients and ERBP (European Renal Best Practice) group its position statement and comments on the KDIGO guidelines. The Croatian Society of Nephrology, Dialysis and Transplantation (HDNDT) has already published its own guidelines based on the recommendations and positive experience of European and international professional societies, as well as on own experience. The latest version of Croatian guidelines was published in 2008. Since then, on the basis of research and clinical practice, there have been numerous changes in the modern understanding of the treatment of anemia in CKD. Consequently, HDNDT hereby publishes a review of the recent recommendations of international professional societies, expressing the attitude about treating anemia in CKD as a basis for new guidelines tailored to the present time.

Ključne riječi
anemia; chronic kidney disease; erythropoiesis stimulating agents; iron; mortality

Hrčak ID: 126932

URI
https://hrcak.srce.hr/126932

[hrvatski]

Posjeta: 1.107 *